Continental Advisors’s Allergan plc AGN Stock Holding History

Continental Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-9,000	Closed	-$2.68M	–	160
2015 Q1	$2.68M	Buy	9,000 +5,000	+125%	+$1.43M	0.59%	56
2014 Q4	$1.03M	Buy	+4,000	New	+$1,000K	0.21%	111
2014 Q2	–	Sell	-6,500	Closed	-$1.34M	–	146
2014 Q1	$1.34M	Buy	+6,500	New	+$1.29M	0.35%	78

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Continental Advisors's AGN Position: Q4 2019 in Review

Continental Advisors sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 16,263 shares — an estimated $2.74M sold.

Continental Advisors first reported a position in AGN in Q1 2016 and held it in 15 quarters. The position peaked at $4.51M in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

Continental Advisors reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
Continental Advisors sold 16,263 Allergan plc shares in Q4 2019, an estimated $2.74M.
Continental Advisors first reported a position in Allergan plc in Q1 2016 and held it in 15 quarters.
Continental Advisors's Allergan plc position peaked at $4.51M in Q3 2018.
957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Continental Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.